T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Acacia Research
ACTG
$449M
| $183K | ﹤0.01% |
43,500
| – | – |
|
|
MITT
2552
TPG Mortgage Investment Trust
MITT
$214M
| $183K | ﹤0.01% |
34,500
+15,500
| +82% | +$80K |
|
2553
Cadiz
CDZI
$295M
| $182K | ﹤0.01% |
72,672
| – | – |
|
2554
First US Bancshares
FUSB
$90.7M
| $182K | ﹤0.01% |
20,950
| – | – |
|
2555
Genie Energy
GNE
$386M
| $182K | ﹤0.01% |
17,602
-6,240
| -26% | -$60.8K |
|
2556
Atomera
ATOM
$212M
| $181K | ﹤0.01% |
29,129
+7,100
| +32% | +$58.2K |
|
|
LUNA
2557
DELISTED
Luna Innovations Incorporated
LUNA
| $181K | ﹤0.01% |
20,615
-11,785
| -36% | -$74.7K |
|
2558
Fossil Group
FOSL
$330M
| $180K | ﹤0.01% |
41,717
+6,100
| +17% | +$25.5K |
|
2559
Gates Industrial Corporation Ltd.
GTES
$7B
| $179K | ﹤0.01% |
15,724
+1,133
| +8% | +$12.5K |
|
2560
SIGA Technologies
SIGA
$207M
| $179K | ﹤0.01% |
24,263
+756
| +3% | +$6.63K |
|
|
ESPR
2561
DELISTED
Esperion Therapeutics
ESPR
| $178K | ﹤0.01% |
28,642
+1,415
| +5% | +$10.1K |
|
2562
On Holding
ONON
$10.6B
| $178K | ﹤0.01% |
10,381
-711
| -6% | -$12.4K |
|
|
BCLI
2563
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $177K | ﹤0.01% |
7,200
| – | – |
|
2564
Personalis
PSNL
$1.54B
| $176K | ﹤0.01% |
88,900
| – | – |
|
2565
AMC Global Media
AMCX
$496M
| $175K | ﹤0.01% |
11,137
-5,081
| -31% | -$101K |
|
|
BORR
2566
Borr Drilling
BORR
$1.25B
| $175K | ﹤0.01% |
35,159
+4,431
| +14% | +$19.7K |
|
|
KZR
2567
DELISTED
Kezar Life Sciences
KZR
| $174K | ﹤0.01% |
2,466
+70
| +3% | +$5.19K |
|
2568
Phibro Animal Health
PAHC
$1.38B
| $174K | ﹤0.01% |
12,964
+131
| +1% | +$1.76K |
|
2569
ZIM Integrated Shipping Services
ZIM
$3.23B
| $174K | ﹤0.01% |
10,100
+300
| +3% | +$6.67K |
|
2570
1-800-Flowers.com
FLWS
$261M
| $173K | ﹤0.01% |
18,084
+4,469
| +33% | +$35.5K |
|
2571
TaskUs
TASK
$667M
| $172K | ﹤0.01% |
+10,200
| New | +$192K |
|
2572
Energy Fuels
UUUU
$3.64B
| $171K | ﹤0.01% |
27,524
+2,266
| +9% | +$15K |
|
|
EQRXW
2573
DELISTED
EQRx, Inc. Warrant
EQRXW
| $171K | ﹤0.01% |
636,924
-15,429
| -2% | -$9.39K |
|
2574
Hillman Solutions
HLMN
$1.71B
| $170K | ﹤0.01% |
23,623
+1,811
| +8% | +$13.6K |
|
2575
TAL Education Group
TAL
$6.43B
| $170K | ﹤0.01% |
24,100
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.